As Colombia undergoes a significant transformation in its healthcare infrastructure, the demand for Precision Medicine (PM) Diagnostic Platforms has surged. The Ministry of Health and Social Protection (Minsalud) and regulatory bodies like INVIMA are increasingly emphasizing the integration of molecular diagnostics into the standard of care for oncology, rare diseases, and infectious disease management.
Shenzhen BioX Medical Co., Ltd. recognizes the unique challenges of the Colombian market—ranging from the high-altitude laboratory requirements in Bogotá to the logistical needs of coastal regions like Cartagena. Our manufacturing capabilities provide the robust, scalable, and highly accurate platforms necessary to support the Plan Decenal de Salud Pública.
Sqm Manufacturing Base
Established Innovation
Expert Specialists
13485 Certified
Integration of robotic handling to reduce human error in nucleic acid extraction and PCR setup, essential for high-volume EPS (Entidades Promotoras de Salud) laboratories.
Developing portable, ruggedized molecular platforms for rural Colombia, ensuring equity in access to genetic screening beyond major urban centers.
Utilizing machine learning to interpret complex genomic data, providing Colombian oncologists with actionable insights for personalized treatment plans.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
We provide full technical documentation dossiers required for INVIMA registration in Colombia.
Cold-chain logistics support for reagents and temperature-sensitive hardware components.
Virtual and on-site training for Colombian lab technicians and biomedical engineers.
Custom branding and localized software interfaces for Colombian diagnostic distributors.
Typically, standard platforms are delivered within 6-8 weeks, accounting for sea freight to Buenaventura or Cartagena, plus customs clearance. Air freight options are available for urgent clinical needs.
We implement a triple-layer quality control system: at the component level, system integration level, and final application testing using standardized clinical samples, ensuring compliance with international and Colombian health standards.
Yes, our systems are designed with open API architectures to seamlessly integrate with most Laboratory Information Systems (LIS) used by major IPS (Institutos Prestadores de Salud) in Colombia.
We offer a comprehensive 24-month warranty and provide replacement parts through our regional partners in Latin America to minimize laboratory downtime.
Partner with Shenzhen BioX Medical Co., Ltd. for reliable, world-class precision diagnostic infrastructure and innovative medical platforms.
Contact Our Growth Director
BioX Medical
